BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2000
View Archived Issues
KRP-297 improves glucose uptake in skeletal muscle in insulin-resistant mice
Read More
Selective factor Xa inhibitor assessed in experimental model of tumor-induced DIC
Read More
Abgenix and Elan enter antibody collaboration for neurological diseases
Read More
IL-1/TNF-alpha suppressant ameliorates intestinal ischemia-reperfusion injury in dogs
Read More
PathoGenesis and Chiron form antibiotic collaboration
Read More
Hemosol completes phase II trial of Hemolink in CABG patients
Read More
Myriad Genetics and Roche to collaborate on cardiovascular drug discovery
Read More
Alexion files IND for C5 inhibitor trial in psoriasis patients
Read More
FDA to review Aptosyn NDA without ODAC input
Read More
Corixa to commence phase II trials of PVAC for treatment of psoriasis
Read More
Synsorb Cd receives fast track designation from FDA for CDAD treatment
Read More
AHP dedicates substantial effort to discovery of PTPase inhibitors
Read More
Knoll compounds with nanomolar affinity for 5-HT, dopamine and adrenergic receptor subtypes
Read More
Preparation, biological activity and use of neurokinin antagonists reported by Sanofi-Synthelabo
Read More
Allelix (now NPS Pharmaceuticals) develops novel pharmaceuticals for neurological and CNS disorders
Read More
Sanofi-Synthelabo presents new muscle relaxant
Read More
Agents for cough in development at Nortran as alternatives to codeine
Read More
Development of nucleoside RT inhibitor effective against resistant HIV strains
Read More
DuPont's new expanded-spectrum NNRTIs advance towards clinical trials
Read More
Respiratory disease collaboration ended by mutual agreement by Millennium and AstraZeneca
Read More
Further investigations on the antiinflammatory effect of rutaecarpine
Read More
Micrologix successfully completes phase II trials of novel peptide antibiotic
Read More
Icos updates clinical program at healthcare conference
Read More
Orally active neurotrophic agent SR-57746A may act by inhibiting tyrosine kinase
Read More
Cephalon's CEP-701 enters phase II trials in prostate cancer
Read More
ImClone Systems achieves milestone in IMC-C225 collaboration with Merck KGaA
Read More
TKT completes pivotal phase III studies of GA-EPO as treatment of renal failure
Read More